ASSET CONTRIBUTION AND SEPARATION AGREEMENT by and between ALLIQUA BIOMEDICAL, INC. and ACQUAMED TECHNOLOGIES, INC. Dated as of May 3, 2019 ASSET CONTRIBUTION AND SEPARATION AGREEMENTAsset Contribution and Separation Agreement • July 25th, 2019 • Adynxx, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledJuly 25th, 2019 Company Industry JurisdictionTHIS ASSET CONTRIBUTION AND SEPARATION AGREEMENT (this “Agreement”) is entered into as of May 3, 2019, by and among: Alliqua BioMedical, Inc., a Delaware corporation (“Alliqua”), and AquaMed Technologies, Inc., a Delaware corporation (“AquaMed”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
ASSET CONTRIBUTION AND SEPARATION AGREEMENTAsset Contribution and Separation Agreement • November 9th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 9th, 2017 Company Industry Jurisdiction[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.